FEASIBILITY STUDY AND LICENSE AGREEMENT BY AND BETWEEN ASKLEPIOS BIOPHARMACEUTICAL, INC. AND SELECTA BIOSCIENCES, INC.Feasibility Study and License Agreement • November 8th, 2019 • Selecta Biosciences Inc • Pharmaceutical preparations • New York
This Feasibility Study and License Agreement (this “Agreement”, as further defined below) is made and entered into as of this 6th day of August, 2019 (the “Effective Date”), by and between Asklepios Biopharmaceutical, Inc., a Delaware corporation with an address at 20 TW Alexander Drive, Suite 110, Research Triangle Park, NC 27514 (“AskBio”), and Selecta Biosciences, Inc., a Delaware corporation with an address at 480 Arsenal Way, Watertown, MA 27709 (“Selecta”). AskBio and Selecta may be referred to herein individually as a “Party” and collectively as the “Parties.”
